Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both
- 18 July 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (5) , 698-704
- https://doi.org/10.1016/j.amjcard.2005.04.048
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrationsEuropean Journal of Heart Failure, 2001
- Role of brain natriuretic peptide in risk stratification of patients with congestive heart failureJournal of the American College of Cardiology, 2001
- Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- Effects of Metoprolol CR in Patients With Ischemic and Dilated CardiomyopathyCirculation, 2000
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart FailureCirculation, 1999
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular DysfunctionCirculation, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Predictors of total mortality and sudden death in mild to moderate heart failureJournal of the American College of Cardiology, 1989
- A Radioimmunoassay for Plasma Aldosterone1Journal of Clinical Endocrinology & Metabolism, 1970